MediPharm Labs Corp. LABS.TO
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · TSX · Canada · medipharmlabs.com
MediPharm Labs Corp. is a GMP-certified cannabis pharmaceutical manufacturer based in Barrie, Ontario, Canada. The company produces pharmaceutical-quality cannabis extracts, concentrates, and active pharmaceutical ingredients for medical markets in Canada, Australia, and Germany. MediPharm holds a Pharmaceutical Drug Establishment License from Health Canada and a U.S. FDA site registration for cannabis pharmaceutical manufacturing.
Key ratios
FreeCashFlowOnSale TTM -0.12
FreeCashFlowOnSale 2025 -0.12
FreeCashFlowOnSale 2024 -0.12
FreeCashFlowOnSale 2023 -0.39
NetIncomeMargin TTM -0.18
NetIncomeMargin 2025 -0.18
NetIncomeMargin 2024 -0.25
NetIncomeMargin 2023 -0.4
ReturnOnAssets TTM -0.11
ReturnOnAssets 2025 -0.11
ReturnOnAssets 2024 -0.09
ReturnOnAssets 2023 -0.13
ReturnOnEquity TTM -0.21
ReturnOnEquity 2025 -0.21
ReturnOnEquity 2024 -0.22
ReturnOnEquity 2023 -0.24
Recent news
MediPharm Labs Announces Voting Results from the 2026 Annual and Special Meeting of Shareholders
2026-06-17 · GlobeNewswire
MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA
2026-05-13 · GlobeNewswire